2026 ICD-10-CM Diagnosis Code D07.5Carcinoma in situ of prostate
ICD-10-CM Codes›C00–D49›D00-D09›D07
- Billable — Valid for Submission
- Chronic Condition
D07.5 is a billable ICD-10-CM diagnosis code for carcinoma in situ of prostate. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 715 through 716, 722 through 724. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Male reproductive system cancers - prostate.
Code Identity
Code Classification
Approximate SynonymsGuidance
Alternate terms and clinical phrases that map to this code.
- Carcinoma in situ of prostate
- Carcinoma in situ of prostatic ducts
- High grade prostatic intraepithelial neoplasia
- Prostatic intraepithelial neoplasia
- Prostatic intraepithelial neoplasia and adjacent atypia
Tabular List NotesGuidance
Coding notes and annotation back-references applicable to this code.
Inclusion Terms
- Prostatic intraepithelial neoplasia III (PIN III)
- Severe dysplasia of prostate
Type 1 Excludes
These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
A type 1 excludes note is a pure excludes note. It means "NOT CODED HERE!" An Excludes1 note indicates that the code excluded should never be used at the same time as the code above the Excludes1 note. An Excludes1 is used when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
Index to Diseases and InjuriesGuidance
Alphabetical index entries that point to this code.
- Dysplasia - See Also: Anomaly;
External Cause of Injuries IndexGuidance
References for this code in the External Cause of Injuries Index.
- Dysplasia
- prostate
- severe
- Neoplasia
- intraepithelial (histologically confirmed)
- prostate (histologically confirmed) (PIN)
- grade III (severe dysplasia)
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Clinical InformationClinical
Prostatic Intraepithelial Neoplasia
a premalignant change arising in the prostatic epithelium, regarded as the most important and most likely precursor of prostatic adenocarcinoma. the neoplasia takes the form of an intra-acinar or ductal proliferation of secretory cells with unequivocal nuclear anaplasia, which corresponds to nuclear grade 2 and 3 invasive prostate cancer.
Table of NeoplasmsClinical
Patient EducationClinical
Prostate Cancer
Cancer is a disease in which cells in the body grow out of control. Prostate cancer begins in the cells of the prostate. The prostate is a gland in the male reproductive system. It lies just below the bladder. It makes fluid that is part of semen.
The full article covers:
- What is prostate cancer?
- What causes prostate cancer?
- Who is more likely to develop prostate cancer?
- What are the symptoms of prostate cancer?
- What are prostate tests and how is prostate cancer diagnosed?
- What are the treatments for prostate cancer?
- Can prostate cancer be prevented?
Read the full article at MedlinePlus
Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.
Convert D07.5 to ICD-9-CMHistory
The closest ICD-9-CM equivalents under the General Equivalence Mappings.
Code HistoryHistory
Questions About D07.5Overview
Is D07.5 (Carcinoma in situ of other and unspecified genital organs) a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report carcinoma in situ of prostate on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
What MS-DRG does D07.5 group to?
When carcinoma in situ of prostate is the principal diagnosis on an inpatient stay, it groups to MS-DRG 715, 716, 722, 723, 724, with relative weights from 0.6117 to 2.2373 depending on complications. Higher weights mean higher Medicare reimbursement.
What is the ICD-9 equivalent of D07.5?
Under the General Equivalence Mappings, carcinoma in situ of prostate converts to ICD-9-CM 233.4 (ca in situ prostate). The mapping is a direct match.
Footnotes
[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:
- The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
- The condition places limitations on self-care, independent living, and social interactions.
